Anika Therapeutics, Inc. (ANIK) vs Fate Therapeutics, Inc. (FATE)
A side-by-side comparison of Anika Therapeutics, Inc. and Fate Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIK
Anika Therapeutics, Inc.
$19.31HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
FATE
Fate Therapeutics, Inc.
$2.35HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ANIK vs FATE
growth of $100 · dividends reinvested · last 10yANIK -57.8% (-8.3%/yr)FATE -18.2% (-2.0%/yr)FATE compounded faster over this window
ANIK FATE
ANIK vs FATE: by the numbers
- •FATE is the larger company ($273M vs $258M market cap).
- •Both run net losses; ANIK's is the smaller (-3.14% vs -1941.09% net margin).
- •Both shrank revenue over the past five years; ANIK's decline was smaller (-2.48% vs -32.98% CAGR).
Metrics side by side
Valuation
| Metric | ANIK | FATE |
|---|---|---|
| Forward P/E | 18.39 | N/A |
| P/S ratio | 2.14 | 42.11 |
| P/B ratio | 1.88 | 1.78 |
| EV / EBITDA | 478.01 | N/A |
| FCF yield | 0.22% | N/A |
Profitability
| Metric | ANIK | FATE |
|---|---|---|
| Gross margin | 62.16% | -94.12% |
| Operating margin | -4.24% | -2222.45% |
| Net margin | -3.14% | -1941.09% |
| ROE | -2.76% | -82.12% |
| ROIC | -3.17% | -58.72% |
Growth (annualized)
| Metric | ANIK | FATE |
|---|---|---|
| Revenue CAGR (5Y) | -2.48% | -32.98% |
| FCF CAGR (5Y) | -39.38% | N/A |
| Total return CAGR (5Y) | -13.40% | -46.86% |
Frequently asked
- Which has grown faster, ANIK or FATE?
- Neither grew: over the past five years both shrank revenue, with ANIK's decline the smaller — ANIK at a -2.48% CAGR versus FATE at -32.98%.
- How have ANIK and FATE total returns compared?
- Over the past 10 years, ANIK delivered -8.51% and FATE delivered -2.31% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.